OP White Papers - random

1. White Paper: Spray Drying Biologics: An Alternative To Freeze Drying 10/16/2024

   Explore how innovative drying technologies can enhance the stability and efficacy of biologics, ensuring successful outcomes in this rapidly growing sector of the pharmaceutical industry.

2. Unlocking The Potential Of Biocatalysis 1/22/2026

   Biocatalysis delivers cleaner, more selective pharma processes while cutting energy use and waste. Engineered enzymes broaden their reach, enabling faster development and greater sustainability.

3. Aggregation In Antibody-Drug Conjugates: Causes And Mitigation 9/1/2025

   Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.

4. Key Selection Criteria For Cell & Gene Therapy CDMOs 3/4/2026

   Choosing the right CDMO requires early internal assessment plus strong technical capability, agility, advocacy, clear communication, and long‑term alignment to meet evolving cell and gene therapy needs.

5. Effect of Shelf Cooling Rate on the Nucleation Temperature of Ice Monitored Using Thermocouples and Wireless Temperature Sensors 5/14/2026

   Freezing conditions shape ice structure, mass transfer resistance, and drying efficiency. Data shows how cooling rate, vial size, and nucleation interact to optimize freeze-drying.

6. Efficient Late-Stage Development Of Biologics 11/25/2025

   Reducing biologics manufacturing costs requires strategic late-stage process development, yield optimization, scale-up, and raw material substitution—all while maintaining product quality and regulatory compliance.

7. The Role Of A Consulting Firm In The IND Process 6/10/2025

   Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

8. Safe, Scalable And GMP-Ready DNA 4/24/2026

   Cell‑free synthetic DNA provides a scalable, safer alternative to plasmids by eliminating bacterial risks, simplifying quality control, and enabling complex sequences under GMP‑aligned conditions.

9. Accelerated API Manufacturing: Combining All Process Development Stages 3/17/2026

   During early-stage development, utilize the key considerations outlined in this paper to avoid common pitfalls and expedite the transition from molecule to market.

10. Early Discovery Of Functional Antibody Leads 11/25/2025

    Early functional screening accelerates therapeutic antibody discovery, improving hit rates and efficiency through advanced platforms like hybridoma upgrades, single B cell workflows, and tailored phage display strategies.